Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Thorsen, Kasper ^a   Schepeler, Troels ^a   Øster, Bodil ^a   Rasmussen, Mads H ^a   Vang, Søren ^a   Wang, Kai ^b,c   Hansen, Kristian Q ^a   Lamy, Philippe ^a,d   Pedersen, Jakob S ^a   Eller, Asger ^a   Mansilla, Francisco ^a   Laurila, Kirsti ^e   Wiuf, Carsten ^d   Laurberg, Søren ^a   Dyrskjøt, Lars ^a   Ørntoft, Torben F ^a   Andersen, Claus L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d AARHUS UNIVERSITY   (Denmark)

^e TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; BINDING PROTEIN; HELIX LOOP HELIX PROTEIN; KINESIN; MESSENGER RNA; OXYSTEROL BINDING PROTEIN RELATED PROTEIN 1; PLECKSTRIN; PROTEIN P53; TRAFFICKING KINESIN BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 12; TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; WNT PROTEIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CARRIER PROTEIN; CHECKPOINT KINASE 1; ISOPROTEIN; OSBP2 PROTEIN, HUMAN; PROTEIN KINASE; TCF12 PROTEIN, HUMAN; TRAK1 PROTEIN, HUMAN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

5' UNTRANSLATED REGION; ACSL5 GENE; AGED; ANK3 GENE; ARTICLE; BINDING SITE; BLADDER CANCER; BRAIN CANCER; CANCER CELL CULTURE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEK1 GENE; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; EXON; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GLYCOSYLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNAL RIBOSOME ENTRY SITE; LASER CAPTURE MICRODISSECTION; LIVER CANCER; LMO7 GENE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; OSBPL1A GENE; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCIN GENE; SIGNAL TRANSDUCTION; STOMACH CANCER; TCF12 GENE; TRAK1 GENE; TRANSCRIPTION INITIATION SITE; TUMOR GENE; TUMOR VOLUME; UGP2 GENE; ALTERNATIVE RNA SPLICING; COHORT ANALYSIS; COLORECTAL TUMOR; DNA MICROARRAY; GENETICS; METABOLISM; PATHOLOGY; WNT SIGNALING PATHWAY;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ALTERNATIVE SPLICING; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARRIER PROTEINS; COHORT STUDIES; COLORECTAL NEOPLASMS; EXONS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; PROTEIN KINASES; RNA, MESSENGER; TRANSCRIPTION INITIATION SITE; WNT SIGNALING PATHWAY;

EID: 80053970951     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-505     Document Type: Article

References (51)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010,
2. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007, 50(1):113-130. 10.1111/j.1365-2559.2006.02549.x, 17204026.
3. Kruhoffer M, Jensen JL, Laiho P, Dyrskjot L, Salovaara R, Arango D, Birkenkamp-Demtroder K, Sorensen FB, Christensen LL, Buhl L, et al. Gene expression signatures for colorectal cancer microsatellite status and HNPCC. Br J Cancer 2005, 92(12):2240-2248. 10.1038/sj.bjc.6602621, 2361815, 15956967.
4. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000, 103(2):311-320. 10.1016/S0092-8674(00)00122-7, 11057903.
5. Shitashige M, Naishiro Y, Idogawa M, Honda K, Ono M, Hirohashi S, Yamada T. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing. Gastroenterology 2007, 132(3):1039-1054. 10.1053/j.gastro.2007.01.007, 17383426.
6. Thorsen K, Mansilla F, Schepeler T, Oster B, Rasmussen MH, Dyrskjot L, Karni R, Akerman M, Krainer AR, Laurberg S, et al. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway. Mol Cell Proteomics 2011, 10(1):M110 002998.
7. Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, Yamashita R, Yamamoto J, Sekine M, Tsuritani K, Wakaguri H, et al. Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome Res 2006, 16(1):55-65. 1356129, 16344560.
8. Davuluri RV, Suzuki Y, Sugano S, Plass C, Huang TH. The functional consequences of alternative promoter use in mammalian genomes. Trends Genet 2008, 24(4):167-177. 10.1016/j.tig.2008.01.008, 18329129.
9. Baek D, Davis C, Ewing B, Gordon D, Green P. Characterization and predictive discovery of evolutionarily conserved mammalian alternative promoters. Genome Res 2007, 17(2):145-155. 10.1101/gr.5872707, 1781346, 17210929.
10. Battey J, Moulding C, Taub R, Murphy W, Stewart T, Potter H, Lenoir G, Leder P. The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell 1983, 34(3):779-787. 10.1016/0092-8674(83)90534-2, 6414718.
11. Marcel V, Hainaut P. p53 isoforms - a conspiracy to kidnap p53 tumor suppressor activity?. Cell Mol Life Sci 2009, 66(3):391-406. 10.1007/s00018-008-8336-3, 18854945.
12. Xu CF, Brown MA, Chambers JA, Griffiths B, Nicolai H, Solomon E. Distinct transcription start sites generate two forms of BRCA1 mRNA. Hum Mol Genet 1995, 4(12):2259-2264. 10.1093/hmg/4.12.2259, 8634696.
13. Van de Wetering M, Castrop J, Korinek V, Clevers H. Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties. Mol Cell Biol 1996, 16(3):745-752. 231054, 8622675.
14. Aerts S, Van Loo P, Thijs G, Mayer H, de Martin R, Moreau Y, De Moor B. TOUCAN 2: the all-inclusive open source workbench for regulatory sequence analysis. Nucleic Acids Res 2005, 33(Web Server issue):W393-396. 1160115, 15980497.
15. Blache P, van de Wetering M, Duluc I, Domon C, Berta P, Freund JN, Clevers H, Jay P. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol 2004, 166(1):37-47. 10.1083/jcb.200311021, 2172132, 15240568.
16. Hatzis P, van der Flier LG, van Driel MA, Guryev V, Nielsen F, Denissov S, Nijman IJ, Koster J, Santo EE, Welboren W, et al. Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol Cell Biol 2008, 28(8):2732-2744. 10.1128/MCB.02175-07, 2293123, 18268006.
17. Van der Flier LG, Sabates-Bellver J, Oving I, Haegebarth A, De Palo M, Anti M, Van Gijn ME, Suijkerbuijk S, Van de Wetering M, Marra G, et al. The Intestinal Wnt/TCF Signature. Gastroenterology 2007, 132(2):628-632. 10.1053/j.gastro.2006.08.039, 17320548.
18. Blom N, Gammeltoft S, Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 1999, 294(5):1351-1362. 10.1006/jmbi.1999.3310, 10600390.
19. la Cour T, Kiemer L, Molgaard A, Gupta R, Skriver K, Brunak S. Analysis and prediction of leucine-rich nuclear export signals. Protein Eng Des Sel 2004, 17(6):527-536. 10.1093/protein/gzh062, 15314210.
20. Emanuelsson O, Brunak S, von Heijne G, Nielsen H. Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc 2007, 2(4):953-971. 10.1038/nprot.2007.131, 17446895.
21. Bendtsen JD, Nielsen H, von Heijne G, Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004, 340(4):783-795. 10.1016/j.jmb.2004.05.028, 15223320.
22. Huang HY, Chien CH, Jen KH, Huang HD. RegRNA: an integrated web server for identifying regulatory RNA motifs and elements. Nucleic Acids Res 2006, 34(Web Server issue):W429-434. 1538840, 16845041.
23. Grillo G, Turi A, Licciulli F, Mignone F, Liuni S, Banfi S, Gennarino VA, Horner DS, Pavesi G, Picardi E, et al. UTRdb and UTRsite (RELEASE 2010): a collection of sequences and regulatory motifs of the untranslated regions of eukaryotic mRNAs. Nucleic Acids Res 2010, 38(Database issue):D75-80. 2808995, 19880380.
24. Finn RD, Mistry J, Tate J, Coggill P, Heger A, Pollington JE, Gavin OL, Gunasekaran P, Ceric G, Forslund K, et al. The Pfam protein families database. Nucleic Acids Res 2010, 38(Database issue):D211-222. 2808889, 19920124.
25. Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, Ponjavic J, Semple CA, Taylor MS, Engstrom PG, Frith MC, et al. Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet 2006, 38(6):626-635. 10.1038/ng1789, 16645617.
26. Yamashita R, Sathira NP, Kanai A, Tanimoto K, Arauchi T, Tanaka Y, Hashimoto SI, Sugano S, Nakai K, Suzuki Y. Genome-wide characterization of transcriptional start sites in humans by integrative transcriptome analysis. Genome Res 2011,
27. Cheong J, Yamada Y, Yamashita R, Irie T, Kanai A, Wakaguri H, Nakai K, Ito T, Saito I, Sugano S, et al. Diverse DNA methylation statuses at alternative promoters of human genes in various tissues. DNA Res 2006, 13(4):155-167. 10.1093/dnares/dsl008, 17068070.
28. Yegnasubramanian S, Wu Z, Haffner MC, Esopi D, Aryee MJ, Badrinath R, He TL, Morgan JD, Carvalho B, Zheng Q, et al. Chromosome-wide mapping of DNA methylation patterns in normal and malignant prostate cells reveals pervasive methylation of gene-associated and conserved intergenic sequences. BMC Genomics 2011, 12(1):313. 10.1186/1471-2164-12-313, 3124442, 21669002.
29. Thorsen K, Sorensen KD, Brems-Eskildsen AS, Modin C, Gaustadnes M, Hein AM, Kruhoffer M, Laurberg S, Borre M, Wang K, et al. Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Mol Cell Proteomics 2008, 7(7):1214-1224. 10.1074/mcp.M700590-MCP200, 18353764.
30. An Y, Zhou Y, Ren G, Tian Q, Lu Y, Li H, Li K, Su T, Xu B, Chen S, et al. Elevated expression of MGb2-Ag/TRAK1 is correlated with poor prognosis in patients with colorectal cancer. Int J Colorectal Dis 2011,
31. Wang D, Claus CL, Rajkumar P, Braunstein M, Moore AJ, Sigvardsson M, Anderson MK. Context-dependent regulation of hematopoietic lineage choice by HEBAlt. J Immunol 2010, 185(7):4109-4117. 10.4049/jimmunol.0901783, 20826759.
32. Wang D, Claus CL, Vaccarelli G, Braunstein M, Schmitt TM, Zuniga-Pflucker JC, Rothenberg EV, Anderson MK. The basic helix-loop-helix transcription factor HEBAlt is expressed in pro-T cells and enhances the generation of T cell precursors. J Immunol 2006, 177(1):109-119.
33. Starr TK, Allaei R, Silverstein KA, Staggs RA, Sarver AL, Bergemann TL, Gupta M, O'Sullivan MG, Matise I, Dupuy AJ, et al. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 2009, 323(5922):1747-1750. 10.1126/science.1163040, 2743559, 19251594.
34. Tsuchihara K, Suzuki Y, Wakaguri H, Irie T, Tanimoto K, Hashimoto S, Matsushima K, Mizushima-Sugano J, Yamashita R, Nakai K, et al. Massive transcriptional start site analysis of human genes in hypoxia cells. Nucleic Acids Res 2009, 37(7):2249-2263. 10.1093/nar/gkp066, 2673422, 19237398.
35. Gardina PJ, Clark TA, Shimada B, Staples MK, Yang Q, Veitch J, Schweitzer A, Awad T, Sugnet C, Dee S, et al. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 2006, 7:325. 10.1186/1471-2164-7-325, 1769375, 17192196.
36. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. The human genome browser at UCSC. Genome Res 2002, 12(6):996-1006. 186604, 12045153.
37. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004, 64(15):5245-5250. 10.1158/0008-5472.CAN-04-0496, 15289330.
38. Andersen CL, Christensen LL, Thorsen K, Schepeler T, Sorensen FB, Verspaget HW, Simon R, Kruhoffer M, Aaltonen LA, Laurberg S, et al. Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. Br J Cancer 2009, 100(3):511-523. 10.1038/sj.bjc.6604884, 2658541, 19156145.
39. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002, 111(2):241-250. 10.1016/S0092-8674(02)01014-0, 12408868.
40. Schmid CD, Praz V, Delorenzi M, Perier R, Bucher P. The Eukaryotic Promoter Database EPD: the impact of in silico primer extension. Nucleic Acids Res 2004, 32(Database issue):D82-85. 308856, 14681364.
41. French PJ, Peeters J, Horsman S, Duijm E, Siccama I, van den Bent MJ, Luider TM, Kros JM, van der Spek P, Sillevis Smitt PA. Identification of differentially regulated splice variants and novel exons in glial brain tumors using exon expression arrays. Cancer Res 2007, 67(12):5635-5642. 10.1158/0008-5472.CAN-06-2869, 17575129.
42. Xi L, Feber A, Gupta V, Wu M, Bergemann AD, Landreneau RJ, Litle VR, Pennathur A, Luketich JD, Godfrey TE. Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Res 2008, 36(20):6535-6547. 10.1093/nar/gkn697, 2582617, 18927117.
43. Satow R, Shitashige M, Kanai Y, Takeshita F, Ojima H, Jigami T, Honda K, Kosuge T, Ochiya T, Hirohashi S, et al. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma. Clin Cancer Res 2010, 16(9):2518-2528. 10.1158/1078-0432.CCR-09-2214, 20388846.
44. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010, 18(1):11-22. 10.1016/j.ccr.2010.05.026, 20579941.
45. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25(17):3389-3402. 10.1093/nar/25.17.3389, 146917, 9254694.
46. Wernersson R, Rapacki K, Staerfeldt HH, Sackett PW, Molgaard A. FeatureMap3D--a tool to map protein features and sequence conservation onto homologous structures in the PDB. Nucleic Acids Res 2006, 34(Web Server issue):W84-88. 1538770, 16845115.
47. Bryson K, McGuffin LJ, Marsden RL, Ward JJ, Sodhi JS, Jones DT. Protein structure prediction servers at University College London. Nucleic Acids Res 2005, 33(Web Server issue):W36-38. 1160171, 15980489.
48. Julenius K, Molgaard A, Gupta R, Brunak S. Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 2005, 15(2):153-164.
49. Jensen LJ, Gupta R, Staerfeldt HH, Brunak S. Prediction of human protein function according to Gene Ontology categories. Bioinformatics 2003, 19(5):635-642. 10.1093/bioinformatics/btg036, 12651722.
50. Hamilton TL, Stoneley M, Spriggs KA, Bushell M. TOPs and their regulation. Biochem Soc Trans 2006, 34(Pt 1):12-16.
51. Kato S, Sekine S, Oh SW, Kim NS, Umezawa Y, Abe N, Yokoyama-Kobayashi M, Aoki T. Construction of a human full-length cDNA bank. Gene 1994, 150(2):243-250. 10.1016/0378-1119(94)90433-2, 7821789.